早期常染色体显性多囊肾病肾衰竭多变量预测模型的开发与验证
本研究基于759例ADPKD患者开发Cox回归模型预测肾衰竭,并在535例早期ADPKD患者中外部验证。完整模型含年龄、性别、肌酐、Mayo影像分类、总二氧化碳、血红蛋白、舒张压和BMI,验证队列C指数0.81,15年内校准良好。
要点
- 完整模型预测早期ADPKD患者15年内肾衰竭风险,验证队列C指数0.81。
- 模型使用常规临床信息,包括年龄、性别、肌酐、Mayo影像分类等。
- 基础模型和完整模型的风险预测在15年内均校准良好。
核心结论
- 在eGFR保留的早期ADPKD患者中,使用常规临床信息的模型可量化15年内肾衰竭风险。
研究设计与样本
- 开发队列为CRISP和HALT-A研究共759例ADPKD患者,验证队列为Mayo临床注册中535例15-49岁、eGFR≥60 ml/min per 1.73 m²的ADPKD患者。
主要发现
- 开发队列基线eGFR 91±29 ml/min per 1.73 m²,中位随访10.2年,16%达到终点。
- 验证队列基线eGFR 90±31 ml/min per 1.73 m²,中位随访5.5年,11%达到终点。
- 完整模型验证队列C指数0.81(95%CI 0.72-0.90),加入ADPKD基因型后为0.75(95%CI 0.62-0.88)。
- 基础模型和完整模型的风险预测在15年内校准良好。
关键数值与推荐
- 肾衰竭终点定义为eGFR<15 ml/min per 1.73 m²、透析或肾移植。
- 完整模型预测变量:年龄、性别、血清肌酐、Mayo影像分类、总二氧化碳、血红蛋白、舒张压和体重指数。
- 基础模型预测变量:年龄、性别、肌酐或eGFR、ADPKD基因型和Mayo影像分类。
临床怎么用
- 可用于早期ADPKD且eGFR保留患者的15年肾衰竭风险预测,辅助早期治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Data were collected from a cohort of 759 patients with autosomal dominant polycystic kidney disease that were followed for a median of 10.2 years. Prognostic models were developed to predict kidney failure using routinely obtained clinical information and externally validated. Risk predictions had good discrimination and calibration over a time horizon of 15 years. BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of kidney failure. Progression is highly variable, and accurate prognostic information is needed to guide early treatment decisions. The objective of this study was to develop a multivariable predictive model for progression to kidney failure. METHODS: We developed prognostic models using Cox regression for the outcome of kidney failure, defined as eGFR <15 ml/min per 1.73 m 2 , dialysis, or kidney transplantation. The development dataset consisted of participants in the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) and Halt Progression of Polycystic Kidney Disease study A (HALT-A) studies. The validation dataset consisted of patients with ADPKD in the Mayo clinical registry aged 15-49 years, with eGFR ≥60 ml/min per 1.73 m 2 . Predictor variables in the base model were age, sex, creatinine or eGFR, ADPKD genotype, and Mayo Imaging Class. Clinical and laboratory data were evaluated in the full model. RESULTS: The development cohort included 759 patients with baseline eGFR of 91±29 ml/min per 1.73 m 2 (mean±SD), of whom 16% reached end point after median (interquartile range) follow-up of 10.2 (5.5-16.7) years. The validation cohort included 535 patients with baseline eGFR of 90±31 ml/min per 1.73 m 2 (mean±SD), of whom 11% reached end point after median (interquartile range) follow-up of 5.5 (1.5-13.7) years. The full model, including age, sex, serum creatinine, Mayo Imaging Class, total carbon dioxide, hemoglobin, diastolic BP, and body mass index, had a C-index of 0.81 (95% confidence interval, 0.72 to 0.90) in the validation cohort and 0.75 (95% confidence interval, 0.62 to 0.88) when ADPKD genotype was also included. Risk predictions from base and full models were well-calibrated out to 15 years. CONCLUSIONS: In persons with early ADPKD and preserved eGFR, a model using routinely obtained clinical information quantified risk of kidney failure over 15 years.
引用
- Yu ASL, Cohen A, Torres VE, et al. Development and Validation of a Multivariable Prediction Model for Kidney Failure in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2025. PMID: 41563252. doi:10.1681/ASN.0000000950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。